GRTS
Gritstone bio, Inc.
Set alert
0.03 USD 0.00 0.00%
0.031 Day range 0.0403
0.0126 52-week range 3.17
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.04
- Prev close
- 0.0322
- Mkt cap
- 3.80M
- Vol
- 55.25M
- Avg vol
- 17.68M
- EPS
- -1.09
- P/E
- -0.03
- Div yield
- 0.00%
More statistics
- Low
- 0.031
- High
- 0.0403
- Forward P/E
- -0.03
- Beta
- 0.50
- Short ratio
- 6.24
- Inst. own
- 29.03%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 13, 2024
- 50-d avg
- 0.314834
- 200-d avg
- 1.01
- 1y target
- 1.00
Financial health
Altman Z-Score
-9.73 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -1.7×
FY 2016 5y median -2.8× FY 2023
P/S 177×
FY 2016 5y median 36.9× FY 2023
P/B 4.5×
FY 2016 5y median 2.2× FY 2023
P/FCF -1.9×
FY 2016 5y median -2.6× FY 2023
EV/EBITDA -2.2×
FY 2016 5y median -2.7× FY 2023
EV/Sales 207×
FY 2016 5y median 32.2× FY 2023
FCF Yield -53.6%
FY 2016 5y median -38.8% FY 2023
Profitability
Gross Margin -470.3%
FY 2016 5y median -470.3% FY 2023
Operating Margin -11617.9%
FY 2016 5y median -2243.8% FY 2023
Net Margin -10405.0%
FY 2016 5y median -2083.1% FY 2023
ROE -267.1%
FY 2016 5y median -66.2% FY 2023
ROIC -98.3%
FY 2016 5y median -57.0% FY 2023
ROA -77.9%
FY 2016 5y median -47.2% FY 2023
Growth (YoY)
Revenue -85.6%
FY 2016 FY 2023
Operating Income -28.4%
FY 2016 FY 2023
EPS (diluted) 3.2%
FY 2016 FY 2023
Free Cash Flow -3.6%
FY 2016 FY 2023
Financial Health
Current Ratio 3.2×
FY 2016 5y median 5.5× FY 2023
Quick Ratio 3.2×
FY 2016 5y median 5.5× FY 2023
Debt / Equity 2.0×
FY 2016 5y median 0.2× FY 2023
Net Debt / EBITDA -0.3×
FY 2016 5y median 0.4× FY 2023
Interest Coverage -38.3×
FY 2016 5y median -97.5× FY 2023
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2023
Annual · latest fiscal year ends 2023-12-31